找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HMG-CoA Reductase Inhibitors; Gerd Schmitz,Michael Torzewski Book 2002 Springer Basel AG 2002 atherosclerosis.cardiovascular.coronary arte

[復(fù)制鏈接]
樓主: 指責
21#
發(fā)表于 2025-3-25 05:03:52 | 只看該作者
22#
發(fā)表于 2025-3-25 08:41:54 | 只看該作者
23#
發(fā)表于 2025-3-25 11:44:58 | 只看該作者
Michael D. Robinson,Michael Eid hypercholesterolemia [.]. Clinical trials have demonstrated that they can induce regression of vascular atherosclerosis, as well as reduction of cardiovascular-related morbidity and mortality, in patients with and without coronary artery disease CAD [.–.]. These trials provide a powerful endorsemen
24#
發(fā)表于 2025-3-25 17:22:12 | 只看該作者
Swarup Bhunia,Mark M.‘Tehranipoortible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
25#
發(fā)表于 2025-3-25 22:26:03 | 只看該作者
26#
發(fā)表于 2025-3-26 00:57:08 | 只看該作者
27#
發(fā)表于 2025-3-26 04:37:57 | 只看該作者
28#
發(fā)表于 2025-3-26 08:42:03 | 只看該作者
Sterol-regulatory element binding proteins (SREBPs): gene-regulatory target of statin action,tible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
29#
發(fā)表于 2025-3-26 13:37:23 | 只看該作者
30#
發(fā)表于 2025-3-26 18:28:43 | 只看該作者
Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease,as the elderly, will also be considered. In addition, we will also consider the relative cost-effectiveness of different statin therapies. Finally, we will consider the cost-effectiveness of statin therapy and resource utilisation in relation to healthcare provision.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 03:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
平果县| 隆德县| 东光县| 正定县| 松江区| 平和县| 陈巴尔虎旗| 宿松县| 津南区| 法库县| 中方县| 昌黎县| 谷城县| 江都市| 佛教| 兴山县| 崇阳县| 博野县| 清新县| 孟津县| 阿图什市| 会昌县| 营山县| 谷城县| 龙州县| 沈阳市| 玛多县| 怀安县| 泾川县| 吐鲁番市| 滨海县| 五大连池市| 合作市| 西和县| 凤阳县| 田阳县| 建始县| 松阳县| 谷城县| 汾阳市| 南投县|